NM_015140.4:c.1651A>G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_015140.4(TTLL12):c.1651A>G(p.Ile551Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000497 in 1,609,702 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015140.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL12 | NM_015140.4 | c.1651A>G | p.Ile551Val | missense_variant | Exon 13 of 14 | ENST00000216129.7 | NP_055955.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTLL12 | ENST00000216129.7 | c.1651A>G | p.Ile551Val | missense_variant | Exon 13 of 14 | 1 | NM_015140.4 | ENSP00000216129.6 | ||
TTLL12 | ENST00000494035.1 | c.-87A>G | 5_prime_UTR_variant | Exon 3 of 4 | 2 | ENSP00000476297.1 | ||||
TTLL12 | ENST00000484711.1 | n.782A>G | non_coding_transcript_exon_variant | Exon 2 of 3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152020Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000781 AC: 19AN: 243236Hom.: 0 AF XY: 0.0000757 AC XY: 10AN XY: 132170
GnomAD4 exome AF: 0.0000466 AC: 68AN: 1457682Hom.: 0 Cov.: 31 AF XY: 0.0000524 AC XY: 38AN XY: 724624
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152020Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74266
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1651A>G (p.I551V) alteration is located in exon 13 (coding exon 13) of the TTLL12 gene. This alteration results from a A to G substitution at nucleotide position 1651, causing the isoleucine (I) at amino acid position 551 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at